Treating obese patients with poorly controlled diabetes: confessions of an insulin therapist (Q33707387)

28 July 2017

1 reference

title

Treating obese patients with poorly controlled diabetes: confessions of an insulin therapist (English)

1 reference

28 July 2017

0 references

Kerr D

1

1 reference

28 July 2017

Cavan D

series ordinal

2

1 reference

28 July 2017

publication date

1 May 1999

1 reference

Diabetes - Metabolism: Research and Reviews

28 July 2017

published in

1 reference

28 July 2017

volume

15

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

219-225

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Promoting weight loss in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

An intensive weight loss programme in established Type 2 diabetes and controls: effects on weight and atherosclerosis risk factors at 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Resistance to Symptomatic Insulin Reactions after Fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Randomised controlled trial of novel, simple, and well supervised weight reducing diets in outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Impact of obesity on insulin action in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Reducing snacks when switching from conventional soluble to lispro insulin treatment: effects on glycaemic control and hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Sibutramine. A review of its contribution to the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Correction of obesity and diabetes in genetically obese mice by leptin gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Taking Care of the Hateful Patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

Five years of heartsink patients in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference